New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
09:21 EDTAKRX, HITKAkorn completes acquisition of Hi-Tech Pharmacal for $640M in cash
Akorn (AKRX) announced that it has completed its previously announced acquisition of Hi-Tech Pharmacal (HITK) for $640M in cash. The combination of Akorn and Hi-Tech will transform the company into a larger, more diversified generic player.
News For AKRX;HITK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 27, 2015
09:50 EDTAKRXAkorn initiated with an Outperform at Avondale
Subscribe for More Information
March 20, 2015
09:34 EDTAKRXAkorn management to meet with William Blair
Subscribe for More Information
07:06 EDTAKRXAkorn launches Phenylephrine HCl Ophthalmic Solution
Subscribe for More Information
March 18, 2015
10:21 EDTAKRXHigh option volume stocks:
Subscribe for More Information
07:32 EDTAKRXAkorn restatement minor, shares attractive, says Jefferies
Subscribe for More Information
07:12 EDTAKRXAkorn shares should recover 'strongly,' says William Blair
William Blair believes shares of Akorn "should recover strongly" with the uncertainty of the annual filing delay being lifted last night. The firm notes management reiterated that the restated financial estimates for 2014 do not affect 2015 guidance. Blair still expects Akorn's 2015 to be a year of "significant cash flow, opportunistic acquisitions, pipeline approvals, and strong growth despite clobetasol competition." It lowered its price target for shares to $58 from $60 and keeps an Outperform rating on the name.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use